D%25252520cold

# D-Cold (Typical formulation: Pseudoephedrine/Chlorpheniramine/Paracetamol) ## Overview D-Cold is a combination product typically containing a decongestant (pseudoephedrine), an antihistamine (chlorpheniramine maleate), and an analgesic/antipyretic (paracetamol). Its primary purpose is the multi-symptom relief of common cold, rhinitis, and influenza-like symptoms. ## Primary Indications * Nasal congestion * Rhinitis and sneezing * Headache and body aches associated with the common cold * Fever reduction ## Adult Dosing * **Standard Dose:** 1 tablet/capsule every 4 to 6 hours as needed. * **Maximum Daily Dose:** Do not exceed 4g of paracetamol in 24 hours (including all other medications containing paracetamol). Usually limited to 4 doses per 24 hours total. ## Pediatric Dosing * **Children < 6 years:** Not recommended without direct medical supervision. * **Children 6–12 years:** 0.5 tablet/capsule every 6 hours, not to exceed 2 doses per 24 hours (or per specific local pediatric protocol). * **Adolescents > 12 years:** Follow adult dosing. ## Dose Adjustments * **Renal Impairment:** Use with caution. Pseudoephedrine may accumulate; dosage interval may need extension. * **Hepatic Impairment:** Reduce paracetamol frequency strictly; avoid in severe liver disease due to hepatotoxicity risk. ## Contraindications * Hypersensitivity to any component (paracetamol, pseudoephedrine, chlorpheniramine). * Severe hypertension or severe coronary artery disease. * Patients currently taking or having taken Monoamine Oxidase Inhibitors (MAOIs) within the last 14 days. * Severe hepatic or renal impairment. * Narrow-angle glaucoma (due to antihistaminic/anticholinergic effects). ## Adverse Effects * **Central Nervous System:** Drowsiness, dizziness, insomnia, nervousness, or excitability. * **Cardiovascular:** Tachycardia, palpitations, or increased blood pressure. * **Anticholinergic:** Dry mouth, blurred vision, urinary retention, or constipation. * **Hepatotoxicity:** Rare, associated with accidental paracetamol overdose. ## Key Drug Interactions * **MAOIs:** Potential for hypertensive crisis. * **CNS Depressants:** Alcohol, sedatives, and hypnotics can potentiate the sedative effects of chlorpheniramine. * **Antihypertensives:** Pseudoephedrine may reduce the effectiveness of blood pressure medication. * **Other Paracetamol Products:** Risk of accidental overdose leading to fulminant hepatic failure. ## Monitoring * **Blood Pressure:** Monitor in patients with controlled hypertension. * **Hepatic function:** Monitor for signs of hepatotoxicity (nausea, RUQ pain, jaundice) if use exceeds 5–7 days. * **Sedation level:** Assessment of alertness, particularly in those operating machinery. ## Clinical Pearls * **Sympathomimetic caution:** Pseudoephedrine can cause jitteriness or insomnia; avoid dosing too close to bedtime. * **Paracetamol awareness:** Counsel patients specifically to avoid doubling up with other "cold and flu" products or prescription analgesics that may also contain paracetamol. * **Anticholinergic burden:** Use with caution in the elderly due to increased risk of urinary retention and cognitive impairment. *** *Disclaimer: This information is for educational purposes only. Always verify current prescribing information, local clinical guidelines, and patient-specific contraindications via official product labeling or institutional formularies before prescribing or administering medication.*